Trial
NCT03339401
The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Adenovirus
Intervention
Standard of Care
Why stopped
terminated due to low enrollment rate
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-25